Skip to main content
Premium Trial:

Request an Annual Quote

LabCorp to Use OncoMethylome's Methylation Reagents for CRC Screening

NEW YORK (GenomeWeb News) – OncoMethylome Sciences will supply Laboratory Corporation of America with reagents used in a stool-based test for colorectal cancer, the Belgian company said today.
 
OncoMethylome will sell to Labcorp reagents used to detect methylation of the Vimentin DNA marker with Methylation-Specific PCR, which can be used to detect colorectal cancer through stool-based tests from patients who are traditionally non-compliant to colorectal screening. OncoMethylome said that it will qualify for milestones linked to LabCorp’s sales of the reagents.
 
OncoMethylome’s gene methylation tests are used to detect early-stage cancer, predict patient response to therapy, and to predict the chance of a cancer’s recurrence.
 
Financial terms of the agreement were not released.

The Scan

Two J&J Doses

Johnson & Johnson says two doses of its SARS-CoV-2 vaccine provides increased protection against symptomatic COVID-19, CNN reports.

Pfizer-BioNTech Vaccine Response in Kids

The Pfizer-BioNTech SARS-CoV-2 vaccine in a lower-dose format appears to generate an immune response among children, according to the Washington Post.

Chicken Changes to Prevent Disease

The Guardian writes that researchers are looking at gene editing chickens to help prevent future pandemics.

PNAS Papers on Siberian Dog Ancestry, Insect Reproduction, Hippocampal Neurogenesis

In PNAS this week: ancestry and admixture among Siberian dogs, hormone role in fruit fly reproduction, and more.